Global Inflammatory Bowel Disease Therapy Market Insights, Forecast to 2028

Inflammatory bowel disease (IBD) is a chronic inflammatory bowel disease of unknown etiology, mainly including ulcerative colitis (UC) and crohn's disease (CD).The etiology may include environmental, infectious, immune and genetic factors.Because the etiology of inflammatory bowel disease is not clear, clinical symptoms are not specific, easy to be confused with other diseases, so the diagnosis is more difficult.Once misdiagnosis is caused by mistreatment, the result is mild but not cured, serious is life-threatening.The diagnosis of inflammatory bowel disease mainly includes the collection of clinical history, colonoscopy, imaging and mucosal histology.

Market Analysis and Insights: Global Inflammatory Bowel Disease Therapy Market

The global Inflammatory Bowel Disease Therapy market size is projected to reach US$ 22210 million by 2028, from US$ 17280 million in 2021, at a CAGR of 3.6% during 2022-2028.

Fully considering the economic change by this health crisis, Ulcerative Colitis accounting for % of the Inflammatory Bowel Disease Therapy global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period.

While Hospital segment is altered to an % CAGR throughout this forecast period.

China Inflammatory Bowel Disease Therapy market size is valued at US$ million in 2021, while the North America and Europe Inflammatory Bowel Disease Therapy are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period.

As for the Europe Inflammatory Bowel Disease Therapy landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Inflammatory Bowel Disease Therapy market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Inflammatory Bowel Disease Therapy market in terms of revenue.

Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Inflammatory Bowel Disease Therapy market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Inflammatory Bowel Disease Therapy market.

Global Inflammatory Bowel Disease Therapy Scope and Market Size

Inflammatory Bowel Disease Therapy market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Inflammatory Bowel Disease Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Ulcerative Colitis

Crohns Disease

Others

Hospital

Medical Research Organization

Other

Johnson & Johnson

AbbVie

Takeda Pharmaceutical Company

Abbott

Celgene Corporation

Innovate Biopharma

Cosmo Pharmaceuticals

Gilead Sciences

Pfizer

North America

United States

Canada

Europe

Germany

France

UK

Italy

Russia

Nordic Countries

Rest of Europe

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Inflammatory Bowel Disease Therapy Market Size Growth Rate by Type, 2017 VS 2021 VS 2028

1.2.2 Ulcerative Colitis

1.2.3 Crohns Disease

1.2.4 Others

1.3 Market by Application

1.3.1 Global Inflammatory Bowel Disease Therapy Market Size Growth Rate by Application, 2017 VS 2021 VS 2028

1.3.2 Hospital

1.3.3 Medical Research Organization

1.3.4 Other

1.4 Study Objectives

1.5 Years Considered

2.1 Global Inflammatory Bowel Disease Therapy Market Perspective (2017-2028)

2.2 Inflammatory Bowel Disease Therapy Growth Trends by Region

2.2.1 Inflammatory Bowel Disease Therapy Market Size by Region: 2017 VS 2021 VS 2028

2.2.2 Inflammatory Bowel Disease Therapy Historic Market Size by Region (2017-2022)

2.2.3 Inflammatory Bowel Disease Therapy Forecasted Market Size by Region (2023-2028)

2.3 Inflammatory Bowel Disease Therapy Market Dynamics

2.3.1 Inflammatory Bowel Disease Therapy Industry Trends

2.3.2 Inflammatory Bowel Disease Therapy Market Drivers

2.3.3 Inflammatory Bowel Disease Therapy Market Challenges

2.3.4 Inflammatory Bowel Disease Therapy Market Restraints

3.1 Global Top Inflammatory Bowel Disease Therapy Players by Revenue

3.1.1 Global Top Inflammatory Bowel Disease Therapy Players by Revenue (2017-2022)

3.1.2 Global Inflammatory Bowel Disease Therapy Revenue Market Share by Players (2017-2022)

3.2 Global Inflammatory Bowel Disease Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Inflammatory Bowel Disease Therapy Revenue

3.4 Global Inflammatory Bowel Disease Therapy Market Concentration Ratio

3.4.1 Global Inflammatory Bowel Disease Therapy Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Inflammatory Bowel Disease Therapy Revenue in 2021

3.5 Inflammatory Bowel Disease Therapy Key Players Head office and Area Served

3.6 Key Players Inflammatory Bowel Disease Therapy Product Solution and Service

3.7 Date of Enter into Inflammatory Bowel Disease Therapy Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Inflammatory Bowel Disease Therapy Historic Market Size by Type (2017-2022)

4.2 Global Inflammatory Bowel Disease Therapy Forecasted Market Size by Type (2023-2028)

5.1 Global Inflammatory Bowel Disease Therapy Historic Market Size by Application (2017-2022)

5.2 Global Inflammatory Bowel Disease Therapy Forecasted Market Size by Application (2023-2028)

6.1 North America Inflammatory Bowel Disease Therapy Market Size (2017-2028)

6.2 North America Inflammatory Bowel Disease Therapy Market Size by Type

6.2.1 North America Inflammatory Bowel Disease Therapy Market Size by Type (2017-2022)

6.2.2 North America Inflammatory Bowel Disease Therapy Market Size by Type (2023-2028)

6.2.3 North America Inflammatory Bowel Disease Therapy Market Share by Type (2017-2028)

6.3 North America Inflammatory Bowel Disease Therapy Market Size by Application

6.3.1 North America Inflammatory Bowel Disease Therapy Market Size by Application (2017-2022)

6.3.2 North America Inflammatory Bowel Disease Therapy Market Size by Application (2023-2028)

6.3.3 North America Inflammatory Bowel Disease Therapy Market Share by Application (2017-2028)

6.4 North America Inflammatory Bowel Disease Therapy Market Size by Country

6.4.1 North America Inflammatory Bowel Disease Therapy Market Size by Country (2017-2022)

6.4.2 North America Inflammatory Bowel Disease Therapy Market Size by Country (2023-2028)

6.4.3 U.S.

6.4.4 Canada

7.1 Europe Inflammatory Bowel Disease Therapy Market Size (2017-2028)

7.2 Europe Inflammatory Bowel Disease Therapy Market Size by Type

7.2.1 Europe Inflammatory Bowel Disease Therapy Market Size by Type (2017-2022)

7.2.2 Europe Inflammatory Bowel Disease Therapy Market Size by Type (2023-2028)

7.2.3 Europe Inflammatory Bowel Disease Therapy Market Share by Type (2017-2028)

7.3 Europe Inflammatory Bowel Disease Therapy Market Size by Application

7.3.1 Europe Inflammatory Bowel Disease Therapy Market Size by Application (2017-2022)

7.3.2 Europe Inflammatory Bowel Disease Therapy Market Size by Application (2023-2028)

7.3.3 Europe Inflammatory Bowel Disease Therapy Market Share by Application (2017-2028)

7.4 Europe Inflammatory Bowel Disease Therapy Market Size by Country

7.4.1 Europe Inflammatory Bowel Disease Therapy Market Size by Country (2017-2022)

7.4.2 Europe Inflammatory Bowel Disease Therapy Market Size by Country (2023-2028)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8.1 Asia-Pacific Inflammatory Bowel Disease Therapy Market Size (2017-2028)

8.2 Asia-Pacific Inflammatory Bowel Disease Therapy Market Size by Type

8.2.1 Asia-Pacific Inflammatory Bowel Disease Therapy Market Size by Type (2017-2022)

8.2.2 Asia-Pacific Inflammatory Bowel Disease Therapy Market Size by Type (2023-2028)

8.2.3 Asia-Pacific Inflammatory Bowel Disease Therapy Market Share by Type (2017-2028)

8.3 Asia-Pacific Inflammatory Bowel Disease Therapy Market Size by Application

8.3.1 Asia-Pacific Inflammatory Bowel Disease Therapy Market Size by Application (2017-2022)

8.3.2 Asia-Pacific Inflammatory Bowel Disease Therapy Market Size by Application (2023-2028)

8.3.3 Asia-Pacific Inflammatory Bowel Disease Therapy Market Share by Application (2017-2028)

8.4 Asia-Pacific Inflammatory Bowel Disease Therapy Market Size by Region

8.4.1 Asia-Pacific Inflammatory Bowel Disease Therapy Market Size by Region (2017-2022)

8.4.2 Asia-Pacific Inflammatory Bowel Disease Therapy Market Size by Region (2023-2028)

8.4.3 China

8.4.4 Japan

8.4.5 South Korea

8.4.6 Southeast Asia

8.4.7 India

8.4.8 Australia

9.1 Latin America Inflammatory Bowel Disease Therapy Market Size (2017-2028)

9.2 Latin America Inflammatory Bowel Disease Therapy Market Size by Type

9.2.1 Latin America Inflammatory Bowel Disease Therapy Market Size by Type (2017-2022)

9.2.2 Latin America Inflammatory Bowel Disease Therapy Market Size by Type (2023-2028)

9.2.3 Latin America Inflammatory Bowel Disease Therapy Market Share by Type (2017-2028)

9.3 Latin America Inflammatory Bowel Disease Therapy Market Size by Application

9.3.1 Latin America Inflammatory Bowel Disease Therapy Market Size by Application (2017-2022)

9.3.2 Latin America Inflammatory Bowel Disease Therapy Market Size by Application (2023-2028)

9.3.3 Latin America Inflammatory Bowel Disease Therapy Market Share by Application (2017-2028)

9.4 Latin America Inflammatory Bowel Disease Therapy Market Size by Country

9.4.1 Latin America Inflammatory Bowel Disease Therapy Market Size by Country (2017-2022)

9.4.2 Latin America Inflammatory Bowel Disease Therapy Market Size by Country (2023-2028)

9.4.3 Mexico

9.4.4 Brazil

10.1 Middle East & Africa Inflammatory Bowel Disease Therapy Market Size (2017-2028)

10.2 Middle East & Africa Inflammatory Bowel Disease Therapy Market Size by Type

10.2.1 Middle East & Africa Inflammatory Bowel Disease Therapy Market Size by Type (2017-2022)

10.2.2 Middle East & Africa Inflammatory Bowel Disease Therapy Market Size by Type (2023-2028)

10.2.3 Middle East & Africa Inflammatory Bowel Disease Therapy Market Share by Type (2017-2028)

10.3 Middle East & Africa Inflammatory Bowel Disease Therapy Market Size by Application

10.3.1 Middle East & Africa Inflammatory Bowel Disease Therapy Market Size by Application (2017-2022)

10.3.2 Middle East & Africa Inflammatory Bowel Disease Therapy Market Size by Application (2023-2028)

10.3.3 Middle East & Africa Inflammatory Bowel Disease Therapy Market Share by Application (2017-2028)

10.4 Middle East & Africa Inflammatory Bowel Disease Therapy Market Size by Country

10.4.1 Middle East & Africa Inflammatory Bowel Disease Therapy Market Size by Country (2017-2022)

10.4.2 Middle East & Africa Inflammatory Bowel Disease Therapy Market Size by Country (2023-2028)

10.4.3 Turkey

10.4.4 Saudi Arabia

10.4.5 UAE

11.1 Johnson & Johnson

11.1.1 Johnson & Johnson Company Details

11.1.2 Johnson & Johnson Business Overview

11.1.3 Johnson & Johnson Inflammatory Bowel Disease Therapy Introduction

11.1.4 Johnson & Johnson Revenue in Inflammatory Bowel Disease Therapy Business (2017-2022)

11.1.5 Johnson & Johnson Recent Developments

11.2 AbbVie

11.2.1 AbbVie Company Details

11.2.2 AbbVie Business Overview

11.2.3 AbbVie Inflammatory Bowel Disease Therapy Introduction

11.2.4 AbbVie Revenue in Inflammatory Bowel Disease Therapy Business (2017-2022)

11.2.5 AbbVie Recent Developments

11.3 Takeda Pharmaceutical Company

11.3.1 Takeda Pharmaceutical Company Company Details

11.3.2 Takeda Pharmaceutical Company Business Overview

11.3.3 Takeda Pharmaceutical Company Inflammatory Bowel Disease Therapy Introduction

11.3.4 Takeda Pharmaceutical Company Revenue in Inflammatory Bowel Disease Therapy Business (2017-2022)

11.3.5 Takeda Pharmaceutical Company Recent Developments

11.4 Abbott

11.4.1 Abbott Company Details

11.4.2 Abbott Business Overview

11.4.3 Abbott Inflammatory Bowel Disease Therapy Introduction

11.4.4 Abbott Revenue in Inflammatory Bowel Disease Therapy Business (2017-2022)

11.4.5 Abbott Recent Developments

11.5 Celgene Corporation

11.5.1 Celgene Corporation Company Details

11.5.2 Celgene Corporation Business Overview

11.5.3 Celgene Corporation Inflammatory Bowel Disease Therapy Introduction

11.5.4 Celgene Corporation Revenue in Inflammatory Bowel Disease Therapy Business (2017-2022)

11.5.5 Celgene Corporation Recent Developments

11.6 Innovate Biopharma

11.6.1 Innovate Biopharma Company Details

11.6.2 Innovate Biopharma Business Overview

11.6.3 Innovate Biopharma Inflammatory Bowel Disease Therapy Introduction

11.6.4 Innovate Biopharma Revenue in Inflammatory Bowel Disease Therapy Business (2017-2022)

11.6.5 Innovate Biopharma Recent Developments

11.7 Cosmo Pharmaceuticals

11.7.1 Cosmo Pharmaceuticals Company Details

11.7.2 Cosmo Pharmaceuticals Business Overview

11.7.3 Cosmo Pharmaceuticals Inflammatory Bowel Disease Therapy Introduction

11.7.4 Cosmo Pharmaceuticals Revenue in Inflammatory Bowel Disease Therapy Business (2017-2022)

11.7.5 Cosmo Pharmaceuticals Recent Developments

11.8 Gilead Sciences

11.8.1 Gilead Sciences Company Details

11.8.2 Gilead Sciences Business Overview

11.8.3 Gilead Sciences Inflammatory Bowel Disease Therapy Introduction

11.8.4 Gilead Sciences Revenue in Inflammatory Bowel Disease Therapy Business (2017-2022)

11.8.5 Gilead Sciences Recent Developments

11.9 Pfizer

11.9.1 Pfizer Company Details

11.9.2 Pfizer Business Overview

11.9.3 Pfizer Inflammatory Bowel Disease Therapy Introduction

11.9.4 Pfizer Revenue in Inflammatory Bowel Disease Therapy Business (2017-2022)

11.9.5 Pfizer Recent Developments

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Author Details

13.3 Disclaimer

List of Tables

    Table 1. Global Inflammatory Bowel Disease Therapy Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028

    Table 2. Key Players of Ulcerative Colitis

    Table 3. Key Players of Crohns Disease

    Table 4. Key Players of Others

    Table 5. Global Inflammatory Bowel Disease Therapy Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028

    Table 6. Global Inflammatory Bowel Disease Therapy Market Size by Region (US$ Million): 2017 VS 2021 VS 2028

    Table 7. Global Inflammatory Bowel Disease Therapy Market Size by Region (2017-2022) & (US$ Million)

    Table 8. Global Inflammatory Bowel Disease Therapy Market Share by Region (2017-2022)

    Table 9. Global Inflammatory Bowel Disease Therapy Forecasted Market Size by Region (2023-2028) & (US$ Million)

    Table 10. Global Inflammatory Bowel Disease Therapy Market Share by Region (2023-2028)

    Table 11. Inflammatory Bowel Disease Therapy Market Trends

    Table 12. Inflammatory Bowel Disease Therapy Market Drivers

    Table 13. Inflammatory Bowel Disease Therapy Market Challenges

    Table 14. Inflammatory Bowel Disease Therapy Market Restraints

    Table 15. Global Inflammatory Bowel Disease Therapy Revenue by Players (2017-2022) & (US$ Million)

    Table 16. Global Inflammatory Bowel Disease Therapy Revenue Share by Players (2017-2022)

    Table 17. Global Top Inflammatory Bowel Disease Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Inflammatory Bowel Disease Therapy as of 2021)

    Table 18. Ranking of Global Top Inflammatory Bowel Disease Therapy Companies by Revenue (US$ Million) in 2021

    Table 19. Global 5 Largest Players Market Share by Inflammatory Bowel Disease Therapy Revenue (CR5 and HHI) & (2017-2022)

    Table 20. Key Players Headquarters and Area Served

    Table 21. Key Players Inflammatory Bowel Disease Therapy Product Solution and Service

    Table 22. Date of Enter into Inflammatory Bowel Disease Therapy Market

    Table 23. Mergers & Acquisitions, Expansion Plans

    Table 24. Global Inflammatory Bowel Disease Therapy Market Size by Type (2017-2022) & (US$ Million)

    Table 25. Global Inflammatory Bowel Disease Therapy Revenue Market Share by Type (2017-2022)

    Table 26. Global Inflammatory Bowel Disease Therapy Forecasted Market Size by Type (2023-2028) & (US$ Million)

    Table 27. Global Inflammatory Bowel Disease Therapy Revenue Market Share by Type (2023-2028)

    Table 28. Global Inflammatory Bowel Disease Therapy Market Size by Application (2017-2022) & (US$ Million)

    Table 29. Global Inflammatory Bowel Disease Therapy Revenue Share by Application (2017-2022)

    Table 30. Global Inflammatory Bowel Disease Therapy Forecasted Market Size by Application (2023-2028) & (US$ Million)

    Table 31. Global Inflammatory Bowel Disease Therapy Revenue Share by Application (2023-2028)

    Table 32. North America Inflammatory Bowel Disease Therapy Market Size by Type (2017-2022) & (US$ Million)

    Table 33. North America Inflammatory Bowel Disease Therapy Market Size by Type (2023-2028) & (US$ Million)

    Table 34. North America Inflammatory Bowel Disease Therapy Market Size by Application (2017-2022) & (US$ Million)

    Table 35. North America Inflammatory Bowel Disease Therapy Market Size by Application (2023-2028) & (US$ Million)

    Table 36. North America Inflammatory Bowel Disease Therapy Market Size by Country (2017-2022) & (US$ Million)

    Table 37. North America Inflammatory Bowel Disease Therapy Market Size by Country (2023-2028) & (US$ Million)

    Table 38. Europe Inflammatory Bowel Disease Therapy Market Size by Type (2017-2022) & (US$ Million)

    Table 39. Europe Inflammatory Bowel Disease Therapy Market Size by Type (2023-2028) & (US$ Million)

    Table 40. Europe Inflammatory Bowel Disease Therapy Market Size by Application (2017-2022) & (US$ Million)

    Table 41. Europe Inflammatory Bowel Disease Therapy Market Size by Application (2023-2028) & (US$ Million)

    Table 42. Europe Inflammatory Bowel Disease Therapy Market Size by Country (2017-2022) & (US$ Million)

    Table 43. Europe Inflammatory Bowel Disease Therapy Market Size by Country (2023-2028) & (US$ Million)

    Table 44. Asia Pacific Inflammatory Bowel Disease Therapy Market Size by Type (2017-2022) & (US$ Million)

    Table 45. Asia Pacific Inflammatory Bowel Disease Therapy Market Size by Type (2023-2028) & (US$ Million)

    Table 46. Asia Pacific Inflammatory Bowel Disease Therapy Market Size by Application (2017-2022) & (US$ Million)

    Table 47. Asia Pacific Inflammatory Bowel Disease Therapy Market Size by Application (2023-2028) & (US$ Million)

    Table 48. Asia Pacific Inflammatory Bowel Disease Therapy Market Size by Region (2017-2022) & (US$ Million)

    Table 49. Asia Pacific Inflammatory Bowel Disease Therapy Market Size by Region (2023-2028) & (US$ Million)

    Table 50. Latin America Inflammatory Bowel Disease Therapy Market Size by Type (2017-2022) & (US$ Million)

    Table 51. Latin America Inflammatory Bowel Disease Therapy Market Size by Type (2023-2028) & (US$ Million)

    Table 52. Latin America Inflammatory Bowel Disease Therapy Market Size by Application (2017-2022) & (US$ Million)

    Table 53. Latin America Inflammatory Bowel Disease Therapy Market Size by Application (2023-2028) & (US$ Million)

    Table 54. Latin America Inflammatory Bowel Disease Therapy Market Size by Country (2017-2022) & (US$ Million)

    Table 55. Latin America Inflammatory Bowel Disease Therapy Market Size by Country (2023-2028) & (US$ Million)

    Table 56. Middle East and Africa Inflammatory Bowel Disease Therapy Market Size by Type (2017-2022) & (US$ Million)

    Table 57. Middle East and Africa Inflammatory Bowel Disease Therapy Market Size by Type (2023-2028) & (US$ Million)

    Table 58. Middle East and Africa Inflammatory Bowel Disease Therapy Market Size by Application (2017-2022) & (US$ Million)

    Table 59. Middle East and Africa Inflammatory Bowel Disease Therapy Market Size by Application (2023-2028) & (US$ Million)

    Table 60. Middle East and Africa Inflammatory Bowel Disease Therapy Market Size by Country (2017-2022) & (US$ Million)

    Table 61. Middle East and Africa Inflammatory Bowel Disease Therapy Market Size by Country (2023-2028) & (US$ Million)

    Table 62. Johnson & Johnson Company Details

    Table 63. Johnson & Johnson Business Overview

    Table 64. Johnson & Johnson Inflammatory Bowel Disease Therapy Product

    Table 65. Johnson & Johnson Revenue in Inflammatory Bowel Disease Therapy Business (2017-2022) & (US$ Million)

    Table 66. Johnson & Johnson Recent Developments

    Table 67. AbbVie Company Details

    Table 68. AbbVie Business Overview

    Table 69. AbbVie Inflammatory Bowel Disease Therapy Product

    Table 70. AbbVie Revenue in Inflammatory Bowel Disease Therapy Business (2017-2022) & (US$ Million)

    Table 71. AbbVie Recent Developments

    Table 72. Takeda Pharmaceutical Company Company Details

    Table 73. Takeda Pharmaceutical Company Business Overview

    Table 74. Takeda Pharmaceutical Company Inflammatory Bowel Disease Therapy Product

    Table 75. Takeda Pharmaceutical Company Revenue in Inflammatory Bowel Disease Therapy Business (2017-2022) & (US$ Million)

    Table 76. Takeda Pharmaceutical Company Recent Developments

    Table 77. Abbott Company Details

    Table 78. Abbott Business Overview

    Table 79. Abbott Inflammatory Bowel Disease Therapy Product

    Table 80. Abbott Revenue in Inflammatory Bowel Disease Therapy Business (2017-2022) & (US$ Million)

    Table 81. Abbott Recent Developments

    Table 82. Celgene Corporation Company Details

    Table 83. Celgene Corporation Business Overview

    Table 84. Celgene Corporation Inflammatory Bowel Disease Therapy Product

    Table 85. Celgene Corporation Revenue in Inflammatory Bowel Disease Therapy Business (2017-2022) & (US$ Million)

    Table 86. Celgene Corporation Recent Developments

    Table 87. Innovate Biopharma Company Details

    Table 88. Innovate Biopharma Business Overview

    Table 89. Innovate Biopharma Inflammatory Bowel Disease Therapy Product

    Table 90. Innovate Biopharma Revenue in Inflammatory Bowel Disease Therapy Business (2017-2022) & (US$ Million)

    Table 91. Innovate Biopharma Recent Developments

    Table 92. Cosmo Pharmaceuticals Company Details

    Table 93. Cosmo Pharmaceuticals Business Overview

    Table 94. Cosmo Pharmaceuticals Inflammatory Bowel Disease Therapy Product

    Table 95. Cosmo Pharmaceuticals Revenue in Inflammatory Bowel Disease Therapy Business (2017-2022) & (US$ Million)

    Table 96. Cosmo Pharmaceuticals Recent Developments

    Table 97. Gilead Sciences Company Details

    Table 98. Gilead Sciences Business Overview

    Table 99. Gilead Sciences Inflammatory Bowel Disease Therapy Product

    Table 100. Gilead Sciences Revenue in Inflammatory Bowel Disease Therapy Business (2017-2022) & (US$ Million)

    Table 101. Gilead Sciences Recent Developments

    Table 102. Pfizer Company Details

    Table 103. Pfizer Business Overview

    Table 104. Pfizer Inflammatory Bowel Disease Therapy Product

    Table 105. Pfizer Revenue in Inflammatory Bowel Disease Therapy Business (2017-2022) & (US$ Million)

    Table 106. Pfizer Recent Developments

    Table 107. Research Programs/Design for This Report

    Table 108. Key Data Information from Secondary Sources

    Table 109. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Inflammatory Bowel Disease Therapy Market Share by Type: 2021 VS 2028

    Figure 2. Ulcerative Colitis Features

    Figure 3. Crohns Disease Features

    Figure 4. Others Features

    Figure 5. Global Inflammatory Bowel Disease Therapy Market Share by Application: 2021 VS 2028

    Figure 6. Hospital Case Studies

    Figure 7. Medical Research Organization Case Studies

    Figure 8. Other Case Studies

    Figure 9. Inflammatory Bowel Disease Therapy Report Years Considered

    Figure 10. Global Inflammatory Bowel Disease Therapy Market Size (US$ Million), Year-over-Year: 2017-2028

    Figure 11. Global Inflammatory Bowel Disease Therapy Market Size, (US$ Million), 2017 VS 2021 VS 2028

    Figure 12. Global Inflammatory Bowel Disease Therapy Market Share by Region: 2021 VS 2028

    Figure 13. Global Inflammatory Bowel Disease Therapy Market Share by Players in 2021

    Figure 14. Global Top Inflammatory Bowel Disease Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Inflammatory Bowel Disease Therapy as of 2021)

    Figure 15. The Top 10 and 5 Players Market Share by Inflammatory Bowel Disease Therapy Revenue in 2021

    Figure 16. North America Inflammatory Bowel Disease Therapy Market Size YoY (2017-2028) & (US$ Million)

    Figure 17. North America Inflammatory Bowel Disease Therapy Market Size Market Share by Type (2017-2028)

    Figure 18. North America Inflammatory Bowel Disease Therapy Market Size Market Share by Application (2017-2028)

    Figure 19. North America Inflammatory Bowel Disease Therapy Market Size Share by Country (2017-2028)

    Figure 20. United States Inflammatory Bowel Disease Therapy Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 21. Canada Inflammatory Bowel Disease Therapy Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 22. Europe Inflammatory Bowel Disease Therapy Market Size YoY (2017-2028) & (US$ Million)

    Figure 23. Europe Inflammatory Bowel Disease Therapy Market Size Market Share by Type (2017-2028)

    Figure 24. Europe Inflammatory Bowel Disease Therapy Market Size Market Share by Application (2017-2028)

    Figure 25. Europe Inflammatory Bowel Disease Therapy Market Size Share by Country (2017-2028)

    Figure 26. Germany Inflammatory Bowel Disease Therapy Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 27. France Inflammatory Bowel Disease Therapy Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 28. U.K. Inflammatory Bowel Disease Therapy Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 29. Italy Inflammatory Bowel Disease Therapy Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 30. Russia Inflammatory Bowel Disease Therapy Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 31. Nordic Countries Inflammatory Bowel Disease Therapy Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 32. Asia-Pacific Inflammatory Bowel Disease Therapy Market Size YoY (2017-2028) & (US$ Million)

    Figure 33. Asia Pacific Inflammatory Bowel Disease Therapy Market Size Market Share by Type (2017-2028)

    Figure 34. Asia Pacific Inflammatory Bowel Disease Therapy Market Size Market Share by Application (2017-2028)

    Figure 35. Asia Pacific Inflammatory Bowel Disease Therapy Market Size Share by Region (2017-2028)

    Figure 36. China Inflammatory Bowel Disease Therapy Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 37. Japan Inflammatory Bowel Disease Therapy Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 38. South Korea Inflammatory Bowel Disease Therapy Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 39. Southeast Asia Inflammatory Bowel Disease Therapy Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 40. India Inflammatory Bowel Disease Therapy Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 41. Australia Inflammatory Bowel Disease Therapy Market Size YoY Growth (2017-2028) & (US$ Million)

List of Figures

    Figure 42. Latin America Inflammatory Bowel Disease Therapy Market Size YoY (2017-2028) & (US$ Million)

    Figure 43. Latin America Inflammatory Bowel Disease Therapy Market Size Market Share by Type (2017-2028)

    Figure 44. Latin America Inflammatory Bowel Disease Therapy Market Size Market Share by Application (2017-2028)

    Figure 45. Latin America Inflammatory Bowel Disease Therapy Market Size Share by Country (2017-2028)

    Figure 46. Mexico Inflammatory Bowel Disease Therapy Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 47. Brazil Inflammatory Bowel Disease Therapy Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 48. Middle East & Africa Inflammatory Bowel Disease Therapy Market Size YoY (2017-2028) & (US$ Million)

    Figure 49. Middle East and Africa Inflammatory Bowel Disease Therapy Market Size Market Share by Type (2017-2028)

    Figure 50. Middle East and Africa Inflammatory Bowel Disease Therapy Market Size Market Share by Application (2017-2028)

    Figure 51. Middle East and Africa Inflammatory Bowel Disease Therapy Market Size Share by Country (2017-2028)

    Figure 52. Turkey Inflammatory Bowel Disease Therapy Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 53. Saudi Arabia Inflammatory Bowel Disease Therapy Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 54. UAE Inflammatory Bowel Disease Therapy Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 55. Johnson & Johnson Revenue Growth Rate in Inflammatory Bowel Disease Therapy Business (2017-2022)

    Figure 56. AbbVie Revenue Growth Rate in Inflammatory Bowel Disease Therapy Business (2017-2022)

    Figure 57. Takeda Pharmaceutical Company Revenue Growth Rate in Inflammatory Bowel Disease Therapy Business (2017-2022)

    Figure 58. Abbott Revenue Growth Rate in Inflammatory Bowel Disease Therapy Business (2017-2022)

    Figure 59. Celgene Corporation Revenue Growth Rate in Inflammatory Bowel Disease Therapy Business (2017-2022)

    Figure 60. Innovate Biopharma Revenue Growth Rate in Inflammatory Bowel Disease Therapy Business (2017-2022)

    Figure 61. Cosmo Pharmaceuticals Revenue Growth Rate in Inflammatory Bowel Disease Therapy Business (2017-2022)

    Figure 62. Gilead Sciences Revenue Growth Rate in Inflammatory Bowel Disease Therapy Business (2017-2022)

    Figure 63. Pfizer Revenue Growth Rate in Inflammatory Bowel Disease Therapy Business (2017-2022)

    Figure 64. Bottom-up and Top-down Approaches for This Report

    Figure 65. Data Triangulation

    Figure 66. Key Executives Interviewed